Downregulated HSD17B6 has also been identified to be associated with non-small-cell lung cancer [11], implying that it might be the key gene contributing to tumorigenesis or tumor progression in lung cancer [11]. Here, HSD17B6 is linked to non-small cell lung carcinoma.